Onderneming Apricus Biosciences Inc Nasdaq
Aandelen
US03832V1098
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | nan % | 2 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 2 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Director of Finance/CFO | 52 | 01-01-19 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 66 | - | |
Anthony Marciano
IRC | Investor Relations Contact | - | 01-08-17 |
Lucas Pilipski
PRN | Corporate Officer/Principal | - | 01-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 01-09-21 | |
Richard Pascoe
CHM | Chairman | 60 | 01-03-13 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 01-01-19 |
Brian Lian
BRD | Director/Board Member | 58 | 01-01-19 |
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 607 744 | 2 573 507 ( 98,69 %) | 0 | 98,69 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
REGNUM CORP. 98.82% | 22 680 000 | 98.82% | 725 760 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,33% | 125 mld. | |
+13,95% | 108 mld. | |
-3,53% | 24,57 mld. | |
+3,32% | 22,82 mld. | |
-10,44% | 18,19 mld. | |
-41,48% | 16,54 mld. | |
-12,62% | 16,5 mld. | |
+0,99% | 13,39 mld. | |
+21,79% | 11,1 mld. |
- Beurs
- Aandelen
- Koers SEEL
- Koers
- Onderneming Apricus Biosciences Inc